RVTY Revvity, Inc. Common Stock
NYSE · Life Sciences Tools & Services · Переглянути на SEC EDGAR ↗ закриття Жов 2, 2026 10-K/10-Q Сер 11, 2026RVTY Знімок акцій Ціна, ринкова капіталізація, P/E, EPS, ROE, борг/власний капітал, діапазон 52 тижнів
RVTY Графік ціни акцій Денні OHLCV з технічними індикаторами — панування, масштабування та налаштування вашого представлення
Гранулярність стовпчиків адаптується до вибраного періоду — наведіть курсор на графік, щоб побачити відкриття/максимум/мінімум/закриття для стовпчика.
| Дата екс-дивіденду | Спліт | Тип |
|---|---|---|
| 04 червня 2001 р. | 2-for-1 | Прямий |
| 11 травня 1992 р. | 2-for-1 | Прямий |
| 02 лютого 1982 р. | 2-for-1 | Прямий |
| 04 лютого 1980 р. | 2-for-1 | Прямий |
Про Revvity, Inc. Common Stock Огляд компанії з Wikipedia
PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics. Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others. By the 21st century, PerkinElmer was focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. It produced analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. PerkinElmer was part of the S&P 500 Index and operated in 190 countries.
Over its history, PerkinElmer has been split in two twice. In 1999, PerkinElmer merged with EG&G, with the ongoing Analytical Instruments Division of Perkin-Elmer keeping that name, while the life sciences division of the company became the separate PE Corporation. In 2022, a split of PerkinElmer resulted in one part, comprising applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but kept the PerkinElmer name. The other part, comprising life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc.
History
Founding
Richard Perkin was attending the Pratt Institute in Brooklyn to study chemical engineering, but left after a year to try his hand on Wall Street. Still interested in the sciences, he gave public lectures on various topics. Charles Elmer ran a firm that supplied court reporters and was nearing retirement when he attended one of Perkin's lectures on astronomy being held at the Brooklyn Institute of Arts and Sciences.
The two struck up a friendship over their shared interest in astronomy, and eventually came up with the idea of starting a firm to produce precision optics. Perkin raised US$15,000 from his relatives, while Elmer added US$5,000, and the firm was initially set up as a partnership on 19 April 1937. Initially, they worked from a small office in Manhattan, but soon opened a production facility in Jersey City. They incorporated the growing firm on 13 December 1939. A further move to Glenbrook in Connecticut in 1941 was quickly followed by another move to Norwalk, Connecticut, where the company remained until 2000. The opening of World War II led to significant expansion as the company produced optics for range finders, bombsights, and reconnaissance systems. This work led to the U.S. Navy awarding them the first "E" for Excellence award in 1942.
Perkin-Elmer retained a strong presence in the military field through the 1960s and at the same time was significantly involved with OAO-3 a 36-inch Ultra Violet Space Telescope and Skylab. They contributed to the Apollo program by development of a CO2 sensor that was, however, supplanted by a Coleman Instruments product. PE at the Norwalk plant also conducted one of the first researches into computer-digital enhancement of scanned images, contracted for application to the Corona spy satellite, film imagery. They were a primary supplier of the optical systems used in many reconnaissance platforms, first in aircraft and high-altitude balloons, and then in reconnaissance satellites. A significant advance was 1955's Transverse Panoramic Camera, which took images on 12 by 14 ft (3.7 by 4.3 m) wide frames that provided single-frame images from horizon to horizon from an aircraft flying at 40,000 ft altitude. Such systems remained a major part of the company's income, capped by the installation of laser retroreflectors on the Moon as part of the Apollo 11 mission.
Elmer died at age 83 in 1954, and the company began trading shares over the counter. The company was listed on the New York Stock Exchange on 13 December 1960. Perkin remained as president and CEO until June 1961, when Robert Lewis, previously of Argus Camera and Sylvania Electric Products, took over these roles. Perkin remained the chairman of the board until his death in 1969.
Semiconductor manufacturing
In 1967, the U.S. Air Force asked Perkin-Elmer to produce an all-optical "masking" system for semiconductor fabrication. Previous systems used a pattern, the "mask", which was pressed onto the surface of the silicon wafer as part of the photolithography process. Small bits of dirt or photoresist would stick the mask and ruin the patterning for subsequent chips, and it was not uncommon for the vast majority of the chips from a given wafer to malfunction. The Air Force, which by the late 1960s was highly reliant on integrated circuits, desired a more reliable system.
Perkin-Elmer responded with the Microprojector, which was essentially a large photocopier system. The mask was placed in a holder and never touched the surface of the chip. Instead, the image was projected onto the surface. Making this work required a complex 16-element lens system that focussed a narrow range of wavelengths of light onto the mask. The remainder of the light from the 1,000 watt mercury-vapor lamp was filtered out. PE also developed a micro-densitometer in 1967 that scanned micro-chips for quality control
Harold Hemstreet was convinced that the concept could be simplified, and Abe Offner began the development of a system using mirrors instead of lenses, which did not suffer from the multispectral focussing problems of lenses. The result of this research was the Projection Scanning Aligner, or Micralign, which made chip making an assembly-line task and improved the number of working chips from perhaps 10% to 70% overnight. Chip prices plummeted as a result, with examples like the MOS 6502 selling for about US$20 while the previous generation of designs like the Motorola 6800 sold for around US$250.
The Micralign was so successful that Perkin-Elmer became the largest single vendor in the chip space in three years. In spite of this success, the company was largely a has-been by the 1980s due to their late response to the introduction of the stepping aligner, which allowed a single small mask to be stepped across the wafer, rather than requiring a single large mask covering the entire wafer. The company never regained their lead, and sold the division to The Silicon Valley Group.
Lab equipment
Perkin Elmer was a leading developer and supplier of lab analytic equipment from the 1950's. By the 1960's the Norwalk/Wilton, CT facilities were developing and producing a wide variety of instruments including multi-spectral spectrometers (IR, visible, UV), gas chromatographs, and atomic absorption spectrometers and Raman spectrometers. The plants housed integrated research, engineering, production (optical and electronic) and support facilities. In the early 1990s, partnered with Cetus Corporation (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry. Analytical-instruments business was also operated from 1954 to 2001 in Germany, by the Bodenseewerk Perkin-Elmer GmbH located in Überlingen at Lake Constance, and England (Perkin Elmer Ltd) at Beaconsfield in Buckinghamshire.
Computer Systems Division
Perkin-Elmer was involved in computer manufacture for a time. The Perkin-Elmer Computer Systems Division was formed through the purchase of Interdata, Inc., an independent computer manufacturer, in 1973–1974 for some US$63 million. This merger made Perkin-Elmer's annual sales rise to over US$200 million. This was also known as Perkin-Elmer's Data Systems Group. The 32-bit computers were very similar to an IBM System/370, but ran the OS/32MT operating system. In 1976, Perkin-Elmer acquired Wangco, a Los Angeles manufacturer of tape drives for $30 million in a stock swap.
The Computer Systems Division had a large presence in Monmouth County, New Jersey, with some 1,700 staff making it one of the county's largest private employers. Its plant in Oceanport had 800 employees alone. By the early-mid-1980s the computing group had sales of $259 million; while profitable, it tended to have reduced visibility within the computing industry due to being owned by a diversified parent.
The Wollongong Group provided the commercial version of the Unix port to the Interdata 7/32 hardware, known as Edition 7 Unix. The port was originally done by the University of Wollongong in New South Wales, Australia, and was the first UNIX port to hardware other than the Digital Equipment Corporation PDP family. By 1982, the Wollongong Group Edition 7 Unix and Programmer's Workbench (PWB) were available on models such as the Perkin-Elmer 3210 and 3240 minicomputers.
In 1985, the computing division of Perkin-Elmer was spun off as Concurrent Computer Corporation, with the goal of giving it and the parallel processing product a clearer identification within the computer industry. At first, the new company was a wholly owned subsidiary of Perkin-Elmer, but with the intentions of putting a minority ownership in the company up for a public stock sale. This was done one in February 1986, with Perkin-Elmer retaining an 82 percent stake in Concurrent. In 1988, there was a merger between Concurrent Computer Corporation and MASSCOMP; as part of the deal, Perkin-Elmer's share in Concurrent was bought out. At that point, Perkin-Elmer said they had culminated their multi-year process of exiting from computer market, allowing them to focus on their primary business segments.
1999
Modern PerkinElmer traces its history back to a merger between divisions of what had been two S&P 500 companies, EG&G Inc. (formerly NYSE: EGG) of Wellesley, Massachusetts and Perkin-Elmer (formerly NYSE: PKN) of Norwalk, Connecticut. On May 28, 1999, the non-government side of EG&G Inc. purchased the Analytical Instruments Division of Perkin-Elmer, its traditional business segment, for US$425 million, also assuming the Perkin-Elmer name and forming the new PerkinElmer company, with new officers and a new board of directors. At the time, EG&G made products for diverse industries including automotive, medical, aerospace and photography.
The old Perkin-Elmer Board of Directors and Officers remained at that reorganized company under its new name, PE Corporation. It had been the Life Sciences division of Perkin-Elmer, and its two component tracking stock business groups, Celera Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB), were centrally involved in the highest profile biotechnology events of the decade, the intense race against the Human Genome Project consortium, which then resulted in the genomics segment of the technology bubble. Perkin-Elmer purchased the Boston operations of NEN Life Sciences in 2001.
Recently
In 1992, the company merged with Applied Biosystems. In 1997 they merged with PerSeptive Biosystems. On July 14, 1999, the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization. In 2006, PerkinElmer sold off the Fluid Sciences division for approximately US$400 million; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand until the end of year 2007.
PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In 2007, it purchased ViaCell, Inc. for US$300 million, which included its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord.
In 2001 Perkin Elmer acquired Packard Bioscience Inc from its majority shareholder, Dick McKernen. This acquisition also came with Agincourt Technologies Inc and consolidated Perkin Elmer's position in laboratory robotics, in particular, liquid handling robots which were to prove essential for the high-throughput sequencing needed for the Human Genome Project.
In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, Pennsylvania specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.
In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.
In September 2011, PerkinElmer bought Caliper Life Sciences for US$600 million.
In December 2014 PerkinElmer acquired Perten Instruments for US$266 million to expand in food testing.
In January 2016, PerkinElmer acquired Swedish firm Vanadis Diagnostics.
In February 2016 PerkinElmer acquired Delta Instruments.
In January 2017, the company announced it would acquire the Indian in vitro diagnostic company, Tulip Diagnostics. In May 2017, the company acquired Euroimmun Medical Laboratory Diagnostics for approximately US$1.3 billion.
In 2018, the company acquired Australian biotech company, RHS Ltd., Chinese manufacturer of analytical instruments, Shanghai Spectrum Instruments Co. Ltd., and France-based company Cisbio Bioassays, which specializes in diagnostics and drug discovery solutions.
In November 2020, PerkinElmer announced it would acquire Horizon Discovery Group for around US$383 million.
In March 2021, PerkinElmer announced that the company has completed its acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). In May of the same year, the business announced it would purchase Nexcelom Bioscience for $260 million and Immunodiagnostic Systems Holdings PLC for $155 million. In June the company announced it would acquire SIRION Biotech, a specialist in viral vector gene delivery methods. In July the business announced it would acquire BioLegend for $5.25 billion.
Acquisition history
Programs
Hubble optics project
Perkin-Elmer's Danbury Optical System unit was commissioned to build the optical components of the Hubble Space Telescope. The construction of the main mirror began in 1979 and completed in 1981. The polishing process ran over budget and behind schedule, producing significant friction with NASA. Due to a miscalibrated null corrector, the primary mirror was also found to have a significant spherical aberration after reaching orbit on STS-31. Perkin-Elmer's own calculations and measurements revealed the primary mirror's surface discrepancies, but the company chose to withhold that data from NASA. A NASA investigation heavily criticized Perkin-Elmer for management failings, disregarding written quality guidelines, and ignoring test data that revealed the miscalibration. Corrective optics were installed on the telescope during the first Hubble service and repair mission STS-61. The correction, Corrective Optics Space Telescope Axial Replacement, was applied entirely to the secondary mirror and replaced existing instrumentation; the aberration of the primary mirror remained uncorrected.
The company agreed to pay US$15 million, essentially forgoing its fees in polishing the mirror, to avoid a threatened liability lawsuit under the False Claims Act by the Federal government. Hughes Aircraft, which acquired the Danbury Optical System unit one month after the launch of the telescope, paid US$10 million. The Justice Department asserted that the companies should have known about the flawed testing. Trade group Aerospace Industries Association protested when concerns were raised in the aerospace industry that aerospace companies might be held liable for failed equipment.
KH-9 Hexagon
Perkin-Elmer built the optical systems for the KH-9 Hexagon series of spy satellites at a facility in Danbury, Connecticut.
Джерело: Wikipedia (Англійська), CC BY-SA 4.0 · Переглянути на Wikipedia ↗
10-річна ефективність Тренди виручки, чистого прибутку, маржі та EPS
Оцінка Співвідношення P/E, P/S, P/B, EV/EBITDA — акція дорога чи дешева?
| Метрика | 5-річний тренд | RVTY | середнє за 5 років | Медіана аналогів | Висновок |
|---|---|---|---|---|---|
| P/E | 46.7середнє за 5 років ≈34.7 | ≈34.7 | 46.0 | Переоцінений | |
| P/S | 3.8середнє за 5 років ≈5.1 | ≈5.1 | 7.1 | Недооцінений | |
| P/B (MRQ) | 2.3середнє за 5 років ≈2.2 | ≈2.2 | 6.8 | Недооцінений | |
| EV / EBITDA | 17.3середнє за 5 років ≈19.0 | ≈19.0 | 25.4 | Недооцінений | |
| Price / FCF (Ціна / FCF) | 21.3середнє за 5 років ≈291.5 | ≈291.5 | · | · | |
| Price / Cash Flow (Ціна / Грошовий потік) | 18.6середнє за 5 років ≈46.4 | ≈46.4 | 28.0 | Недооцінений | |
| EV / Revenue (EV / Дохід) | 4.6середнє за 5 років ≈6.1 | ≈6.1 | · | · | |
| EV / FCF | 25.8середнє за 5 років ≈341.5 | ≈341.5 | · | · | |
| Ціна / Матеріальний чистий капітал (MRQ) | 3.4 | · | · | · |
Медіана аналогічних компаній розраховується на стандартизованій основі для кожного показника і може не завжди відповідати базі TTM/MRQ, показаній для цієї акції.
Прибутковість Валова, операційна та чиста маржа; ROE, ROA, ROIC
| Метрика | 5-річний тренд | RVTY | середнє за 5 років | Медіана аналогів | Висновок |
|---|---|---|---|---|---|
| Operating Margin (Операційна маржа) | 12.5%середнє за 5 років ≈16.9% | ≈16.9% | 17.4% | Слабкий | |
| EBITDA Margin (Маржа EBITDA) | 26.7%середнє за 5 років ≈30.0% | ≈30.0% | 18.6% | Слабкий | |
| Pretax Margin (До оподаткування маржа) | 9.4%середнє за 5 років ≈14.5% | ≈14.5% | 17.9% | Слабкий | |
| Net Profit Margin (Маржа чистого прибутку) | 8.5%середнє за 5 років ≈15.9% | ≈15.9% | 14.7% | Слабкий | |
| ROA | 2.0%середнє за 5 років ≈4.2% | ≈4.2% | 9.8% | Слабкий | |
| ROE | 3.3%середнє за 5 років ≈7.4% | ≈7.4% | 11.0% | Слабкий | |
| ROIC | 3.0%середнє за 5 років ≈4.3% | ≈4.3% | 13.4% | Слабкий |
Фінансове здоровʼя Борг, ліквідність, платоспроможність — міцність балансу
| Метрика | 5-річний тренд | RVTY | середнє за 5 років | Медіана аналогів | Висновок |
|---|---|---|---|---|---|
| Борг / Власний капітал (MRQ) | 0.4середнє за 5 років ≈0.5 | ≈0.5 | 0.2 | Високий борг | |
| Поточний коефіцієнт (MRQ) | 1.8середнє за 5 років ≈2.3 | ≈2.3 | 1.8 | Відповідно | |
| Quick Ratio (Коефіцієнт швидкої ліквідності) | 1.3середнє за 5 років ≈1.5 | ≈1.5 | 1.0 | Висока ліквідність | |
| Довгостроковий борг / Власний капітал (MRQ) | 0.4середнє за 5 років ≈0.5 | ≈0.5 | 0.4 | Відповідно |
Зростання Зростання виручки, EPS та чистого прибутку: рік до року, 3-річний CAGR, 5-річний CAGR
| Метрика | 5-річний тренд | RVTY | середнє за 5 років | Медіана аналогів | Висновок |
|---|---|---|---|---|---|
| Revenue YoY (Виторг рік до року) | 3.7%середнє за 5 років ≈-5.1% | ≈-5.1% | · | · | |
| Revenue CAGR 3Y (CAGR виторгу 3 роки) | -4.8%середнє за 5 років ≈-8.4% | ≈-8.4% | · | · | |
| Revenue CAGR 5Y (CAGR виторгу 5 років) | -5.5% | · | · | · | |
| EPS YoY | -5.9%середнє за 5 років ≈-12.6% | ≈-12.6% | · | · | |
| Net Income YoY (Чистий прибуток рік до року) | -10.8%середнє за 5 років ≈-12.0% | ≈-12.0% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 роки) | -22.8%середнє за 5 років ≈-21.0% | ≈-21.0% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 років) | -20.4% | · | · | · | |
| Net Income CAGR 3Y (CAGR чистого прибутку 3 роки) | -24.9%середнє за 5 років ≈-20.2% | ≈-20.2% | · | · | |
| Net Income CAGR 5Y (CAGR чистого прибутку 5 років) | -19.8% | · | · | · |
Ефективність капіталу Оборотність активів, оборотність запасів, оборотність дебіторської заборгованості
| Метрика | 5-річний тренд | RVTY | середнє за 5 років | Медіана аналогів | Висновок |
|---|---|---|---|---|---|
| Asset Turnover (Оборотність активів) | 0.2середнє за 5 років ≈0.3 | ≈0.3 | 0.6 | Слабкий | |
| Receivables Turnover (Оборотність дебіторської заборгованості) | 4.1середнє за 5 років ≈4.5 | ≈4.5 | 5.5 | Слабкий | |
| Revenue / Employee (Виручка / співробітник (річна виручка ÷ кількість співробітників (штатний розпис, yfinance). Похідне — не збережена концепція SEC-XBRL).) | ≈$259.6K | · | · | · |
значення · ≈ середнє за 5 років · медіана галузі · вердикт відносно медіани
Дивіденди Дивідендна дохідність, коефіцієнт виплат, історія дивідендів, 5-річний CAGR
| Дата екс-дивіденду | Сума | Валюта | Дохідність |
|---|---|---|---|
| Лип 17, 2026 | $0,07 | USD | ≈0.25% |
| Кві 17, 2026 | $0,07 | USD | ≈0.30% |
| Січ 16, 2026 | $0,07 | USD | ≈0.25% |
| Жов 17, 2025 | $0,07 | USD | ≈0.30% |
| Лип 18, 2025 | $0,07 | USD | ≈0.30% |
| Кві 17, 2025 | $0,07 | USD | ≈0.30% |
| Січ 17, 2025 | $0,07 | USD | ≈0.24% |
| Жов 18, 2024 | $0,07 | USD | ≈0.23% |
| Лип 19, 2024 | $0,07 | USD | ≈0.26% |
| Кві 18, 2024 | $0,07 | USD | ≈0.28% |
| Січ 18, 2024 | $0,07 | USD | ≈0.26% |
| Жов 19, 2023 | $0,07 | USD | ≈0.28% |
| Лип 20, 2023 | $0,07 | USD | ≈0.22% |
| Кві 20, 2023 | $0,07 | USD | ≈0.21% |
| Січ 19, 2023 | $0,07 | USD | ≈0.21% |
| Жов 20, 2022 | $0,07 | USD | ≈0.22% |
| Лип 21, 2022 | $0,07 | USD | ≈0.19% |
| Кві 21, 2022 | $0,07 | USD | ≈0.18% |
| Січ 20, 2022 | $0,07 | USD | ≈0.16% |
| Жов 21, 2021 | $0,07 | USD | ≈0.16% |
Історія прибутків EPS фактичний проти прогнозу, сюрприз %, коефіцієнт перевищення, дата наступного звіту про прибутки
| Період | Звіт | EPS (факт) | EPS прогноз | Сюрприз |
|---|---|---|---|---|
| 30 червня 2026 р. | Лип 27, 2026 | $1.41 | $1.25 | 13.1% |
| 31 березня 2026 р. | $1.06 | $1.04 | 2.3% | |
| 31 грудня 2025 р. | $1.70 | $1.58 | 7.4% | |
| 30 вересня 2025 р. | $1.18 | $1.16 | 1.7% | |
| 30 червня 2025 р. | $1.18 | $1.16 | 1.5% | |
| 31 березня 2025 р. | $1.01 | $0.97 | 4.3% |
Повні фундаментальні показники Усі показники за роками — звіт про прибутки та збитки, баланс, рух грошових коштів
Звіт про прибутки та збитки
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B | $3.78B | $2.88B | $2.78B | $2.26B | $2.12B | $2.10B | $2.24B | |
| Cost of Revenue | · | · | · | · | · | · | · | $1.44B | $709M | $665M | $696M | $708M | |
| Gross Profit | · | · | · | $1.99B | $2.43B | $2.11B | $1.40B | $1.34B | $1.07B | $1.01B | $964M | $1.00B | |
| R&D Expense | $216M | $197M | $217M | $222M | $200M | $146M | $189M | $194M | $139M | $124M | $113M | $108M | |
| SG&A Expense | $992M | $994M | $1.02B | $1.03B | $975M | $716M | $815M | $812M | $626M | $590M | $587M | $648M | |
| Operating Income | $357M | $347M | $301M | $743M | $1.26B | $867M | $362M | $324M | $296M | $295M | $251M | $165M | |
| Interest Expense | · | · | · | · | · | $50M | $64M | $67M | $44M | $42M | $38M | $36M | |
| Interest Income | $31M | $73M | $72M | $4M | $2M | $1M | $1M | $1M | $3M | $702.0K | $673.0K | $667.0K | |
| Other Non-op | $-88M | $-31M | $-118M | $-91M | $-3M | $-5M | $-6M | $-13M | $43M | $-15M | $-5M | $-6M | |
| Pretax Income | $268M | $316M | $183M | $652M | $1.20B | $800M | $237M | $258M | $297M | $244M | $209M | $124M | |
| Income Tax | $28M | $33M | $3M | $139M | $314M | $170M | $9M | $20M | $140M | $28M | $20M | $-6M | |
| Net Income | $241M | $270M | $693M | $569M | $943M | $728M | $228M | $238M | $293M | $234M | $212M | $158M | |
| EPS (Basic) | $2.07 | $2.21 | $5.56 | $4.51 | $8.12 | $6.52 | $2.06 | $2.15 | $2.67 | $2.14 | $1.89 | $1.40 | |
| EPS (Diluted) | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 | $6.49 | $2.04 | $2.13 | $2.64 | $2.12 | $1.87 | $1.39 | |
| Shares (Basic) | 116,542,000 | 122,756,000 | 124,704,000 | 126,155,000 | 116,165,000 | 111,514,000 | 110,827,000 | 110,561,000 | 109,857,000 | 109,478,000 | 112,507,000 | 112,593,000 | |
| Shares (Diluted) | 116,595,000 | 122,822,000 | 124,812,000 | 126,426,000 | 116,674,000 | 112,085,000 | 111,501,000 | 111,534,000 | 110,859,000 | 110,313,000 | 113,315,000 | 113,739,000 | |
| EBITDA | $762M | $775M | $732M | $1.17B | $1.69B | $1.23B | $576M | $504M | $410M | $383M | $398M | $327M |
Баланс
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $920M | $1.16B | $913M | $454M | $603M | $387M | $192M | $163M | $202M | $359M | $238M | $175M | |
| Short-term Investments | · | $0 | $690M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $745M | $632M | $633M | $613M | $708M | $1.16B | $725M | $633M | $552M | $426M | $415M | $471M | |
| Inventory | $379M | $368M | $428M | $405M | $426M | $515M | $357M | $338M | $352M | $247M | $259M | $285M | |
| Other Current Assets | $196M | $186M | $337M | $122M | $148M | $167M | $100M | $101M | $94M | $99M | $64M | $138M | |
| Current Assets | $2.24B | $2.35B | $3.00B | $3.29B | $2.44B | $2.24B | $1.37B | $1.23B | $1.20B | $1.19B | $1.03B | $1.07B | |
| PP&E (Net) | $479M | $482M | $510M | $483M | $486M | $368M | $318M | $319M | $298M | $145M | $138M | $176M | |
| PP&E (Gross) | $1.09B | $982M | $983M | $857M | $844M | $818M | $702M | $680M | $631M | $428M | $402M | $493M | |
| Accum. Depreciation | $614M | $500M | $473M | $374M | $359M | $450M | $383M | $362M | $333M | $282M | $264M | $317M | |
| Goodwill | $6.61B | $6.46B | $6.53B | $6.48B | $6.63B | $2.64B | $3.11B | $2.95B | $3.00B | $2.25B | $2.24B | $2.24B | |
| Intangibles | $2.35B | $2.64B | $3.02B | $3.38B | $3.82B | $1.37B | $1.28B | $1.20B | $1.35B | $420M | $486M | $490M | |
| Other Non-current Assets | $323M | $288M | $343M | $311M | $317M | $333M | $284M | $270M | $244M | $205M | $198M | $107M | |
| Total Assets | $12.17B | $12.39B | $13.56B | $14.13B | $15.00B | $7.96B | $6.54B | $5.98B | $6.09B | $4.28B | $4.17B | $4.13B | |
| Accounts Payable | $185M | $167M | $204M | $273M | $325M | $327M | $236M | $221M | $222M | $168M | $141M | $174M | |
| Accrued Liabilities | $557M | $485M | $524M | $528M | $679M | $944M | $503M | $529M | $501M | $400M | $382M | $403M | |
| Current Liabilities | $1.33B | $653M | $1.45B | $1.54B | $1.21B | $1.65B | $763M | $772M | $951M | $603M | $561M | $597M | |
| Capital Leases | $148M | $152M | $133M | $170M | $147M | $188M | $146M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Liabilities | $807M | $771M | $931M | $1.11B | $1.43B | $775M | $751M | $742M | $849M | $460M | $465M | $443M | |
| Total Liabilities | $4.92B | $4.73B | $5.69B | $6.75B | $7.86B | $4.22B | $3.72B | $3.39B | $3.59B | $2.12B | $2.06B | $2.09B | |
| Long-term Debt | $3.22B | $3.15B | $3.90B | $4.39B | $4.98B | $1.99B | $2.07B | $1.89B | $2.01B | $1.05B | $480M | $1.05B | |
| Total Debt | $3.22B | $3.15B | $3.90B | $4.39B | $4.98B | $1.61B | $2.06B | $1.88B | $1.79B | $1.05B | $1.01B | $1.05B | |
| Common Stock | $112M | $121M | $123M | $126M | $126M | $112M | $111M | $111M | $110M | $110M | $112M | $112M | |
| Retained Earnings | $6.05B | $5.85B | $5.61B | $4.95B | $4.42B | $3.51B | $2.81B | $2.60B | $2.38B | $2.12B | $1.99B | $1.81B | |
| AOCI | $-222M | $-396M | $-277M | $-447M | $-163M | $-32M | $-200M | $-176M | $-47M | $-101M | $-46M | $25M | |
| Stockholders' Equity | $7.25B | $7.67B | $7.87B | $7.38B | $7.14B | $3.74B | $2.81B | $2.58B | $2.50B | $2.15B | $2.11B | $2.04B | |
| Liabilities + Equity | $12.17B | $12.39B | $13.56B | $14.13B | $15.00B | $7.96B | $6.54B | $5.98B | $6.09B | $4.28B | $4.17B | $4.13B | |
| Shares Outstanding | 112,281,000 | 120,646,000 | 0 | 126,300,000 | 126,241,000 | 112,090,000 | 111,140,000 | 110,361,000 | 110,361,000 | 109,617,000 | 112,481,000 | 112,481,000 |
Грошовий потік
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $405M | $428M | $432M | $427M | $311M | $202M | $214M | $181M | $105M | $100M | $105M | $110M | |
| Stock-based Comp | $23M | $38M | $41M | $52M | $30M | $27M | $32M | $29M | $25M | $17M | $17M | $14M | |
| Deferred Tax | $-61M | $-102M | $-124M | $-106M | $-55M | $-35M | $-61M | $-51M | $29M | $-5M | $-10M | $-34M | |
| Amort. of Intangibles | $336M | $359M | $365M | $371M | $257M | $161M | $164M | $136M | $74M | $72M | $77M | $81M | |
| Restructuring | · | $18M | $27M | $14M | $-14M | $8M | $29M | $11M | $13M | $5M | $14M | $13M | |
| Other Non-cash | $-25M | $-6M | $-951M | $-262M | $126M | $-82M | $-48M | $-85M | $-163M | $4M | $-48M | $26M | |
| Operating Cash Flow | $583M | $628M | $91M | $680M | $1.41B | $892M | $363M | $311M | $288M | $351M | $287M | $282M | |
| CapEx | $74M | $87M | $81M | $86M | $86M | $64M | $76M | $93M | $39M | $32M | $28M | $27M | |
| Investing Cash Flow | $-17M | $776M | $1.31B | $-133M | $-4.11B | $-504M | $-488M | $-160M | $-1.27B | $-84M | $-101M | $-296M | |
| Stock Repurchased | $821M | $370M | $389M | $81M | $73M | $7M | $6M | $57M | $4M | $152M | $76M | $66M | |
| Net Stock Activity | $-821M | $-370M | $-389M | $-81M | $-73M | $-7M | $-6M | $-57M | $-4M | $-152M | $-76M | $-66M | |
| Dividends Paid | $33M | $34M | $35M | $35M | $32M | $31M | $31M | $31M | $31M | $31M | $32M | $32M | |
| Financing Cash Flow | $-858M | $-1.13B | $-947M | $-662M | $2.94B | $-203M | $-150M | $-179M | $782M | $-115M | $-107M | $31M | |
| Net Change in Cash | $-243M | $250M | $444M | $-149M | $217M | $211M | $26M | $-36M | $-174M | $138M | $63M | $2M | |
| Taxes Paid | $131M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $509M | $542M | $10M | $594M | $1.31B | $815M | $287M | $218M | $249M | $319M | $257M | $253M | |
| Levered FCF | · | · | · | · | · | $775M | $226M | $156M | $226M | $282M | $224M | $218M |
Прибутковість
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 60.1% | · | 55.8% | 48.4% | 48.3% | 47.5% | 47.9% | 45.3% | 44.9% | |
| Operating Margin | 12.5% | 12.6% | 10.9% | 22.4% | 26.3% | 25.9% | 12.6% | 11.7% | 13.5% | 13.4% | 12.7% | 9.4% | |
| Net Margin | 8.5% | 9.8% | 25.2% | 17.2% | 18.6% | 19.2% | 7.9% | 8.6% | 13.0% | 11.1% | 9.4% | 7.0% | |
| Pretax Margin | 9.4% | 11.5% | 6.7% | 19.7% | 25.3% | 24.0% | 8.2% | 9.3% | 13.2% | 11.5% | 10.8% | 7.6% | |
| EBITDA Margin | 26.7% | 28.1% | 26.6% | 35.3% | 33.4% | 32.4% | 20.0% | 18.2% | 18.2% | 18.1% | 17.6% | 14.6% | |
| ROA | 2.0% | 2.1% | 5.0% | 3.9% | 8.2% | 10.0% | 3.6% | 3.9% | 5.6% | 5.5% | 5.1% | 3.9% | |
| ROE | 3.3% | 3.5% | 8.9% | 7.9% | 13.4% | 20.9% | 8.2% | 9.2% | 12.6% | 11.0% | 10.2% | 7.8% | |
| ROIC | 3.0% | 2.9% | 2.5% | 5.0% | 8.1% | 14.7% | 7.1% | 6.7% | 3.8% | 7.8% | 8.0% | 6.5% |
Ліквідність та платоспроможність
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.6 | 2.1 | 2.1 | 2.0 | 1.4 | 1.8 | 1.6 | 1.3 | 2.0 | 1.8 | 1.8 | |
| Quick Ratio | 1.3 | 2.7 | 1.5 | 0.7 | 1.4 | 0.9 | 1.2 | 1.0 | 0.8 | 1.3 | 1.2 | 1.1 | |
| Debt / Equity | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 | 0.4 | 0.7 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.4 | 0.4 | 0.4 | 0.5 | 0.7 | 0.4 | 0.7 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | · | · | · | 19.7 | 5.7 | 4.8 | 6.9 | 6.8 | 7.5 | 5.8 |
Ефективність
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | · | · | · | · | · | · | · | 4.2 | 2.4 | 2.6 | 2.8 | 2.9 | |
| Receivables Turnover | 4.1 | 4.4 | 4.4 | 5.0 | 4.7 | 4.0 | 4.2 | 4.7 | 4.6 | 5.0 | 5.0 | 4.8 |
На акцію
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.57 | $63.55 | $63.79 | $58.46 | $56.57 | $33.33 | $25.44 | $23.37 | $22.68 | $19.22 | $18.84 | $18.16 | |
| Revenue / Share | $24.50 | $22.43 | $22.04 | $26.20 | $43.43 | $33.75 | $25.86 | $24.91 | $20.36 | $19.18 | $19.97 | $19.67 | |
| Cash Flow / Share | $5.00 | $5.12 | $0.73 | $5.38 | $12.09 | $7.96 | $3.26 | $2.79 | $2.60 | $3.18 | $2.53 | $2.48 | |
| Cash / Share | $8.19 | $9.64 | $7.40 | $3.60 | $4.90 | $3.59 | $1.73 | $1.47 | $1.83 | $3.21 | $2.12 | $1.55 | |
| Dividend / Share | $0.28 | $0.28 | $0.28 | $0.28 | · | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | |
| EPS (TTM) | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 | $6.49 | $2.04 | $2.13 | $2.64 | $2.12 | $1.87 | $1.39 |
Темпи зростання
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | 0.16% | -17.0% | -13.5% | 1.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -4.8% | -10.4% | -10.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -5.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -5.9% | -60.4% | 23.3% | -44.3% | 24.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.8% | -35.2% | -5.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -20.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -10.8% | -61.0% | 21.8% | -39.6% | 29.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -34.1% | -1.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -19.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 1.0% | · | · | · | · | · | · | · | · | · | · | · |
Оцінка (TTM)
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B | $3.78B | $2.88B | $2.78B | $2.26B | $2.12B | $2.10B | $2.24B | |
| Net Income TTM | $241M | $270M | $693M | $569M | $943M | $728M | $228M | $238M | $293M | $234M | $212M | $158M | |
| Market Cap | $10.86B | $13.51B | $13.49B | $17.71B | $25.38B | $16.08B | $10.73B | $8.55B | $8.07B | $5.84B | $6.00B | $4.96B | |
| Enterprise Value | $13.16B | $15.50B | $15.79B | $21.65B | $29.74B | $17.29B | $12.61B | $10.26B | $9.66B | $6.53B | $6.78B | $5.83B | |
| P/E | 46.7 | 50.9 | 19.7 | 31.2 | 24.9 | 22.1 | 47.6 | 36.3 | 27.7 | 24.6 | 28.6 | 31.7 | |
| P/S | 3.8 | 4.9 | 4.9 | 5.3 | 6.6 | 4.3 | 3.7 | 3.1 | 3.6 | 2.8 | 2.9 | 2.2 | |
| P/B | 1.5 | 1.8 | 1.7 | 2.4 | 3.6 | 4.3 | 3.8 | 3.3 | 3.2 | 2.7 | 2.8 | 2.4 | |
| P / Cash Flow | 18.6 | 21.5 | 147.8 | 26.1 | 18.0 | 18.0 | 29.5 | 27.5 | 28.0 | 16.7 | 20.9 | 17.6 | |
| P / FCF | 21.3 | 24.9 | 1362.2 | 29.8 | 19.4 | 19.7 | 37.4 | 39.2 | 32.4 | 18.3 | 23.3 | 19.6 | |
| EV / EBITDA | 17.3 | 20.0 | 21.6 | 18.5 | 17.6 | 14.1 | 21.9 | 20.3 | 23.6 | 17.0 | 17.0 | 17.8 | |
| EV / FCF | 25.8 | 28.6 | 1594.1 | 36.4 | 22.7 | 21.2 | 43.9 | 47.1 | 38.7 | 20.5 | 26.3 | 23.1 | |
| EV / Revenue | 4.6 | 5.6 | 5.7 | 6.5 | 7.8 | 4.6 | 4.4 | 3.7 | 4.3 | 3.1 | 3.2 | 2.6 | |
| Dividend Yield | 0.30% | 0.26% | 0.26% | 0.20% | 0.13% | 0.19% | 0.29% | 0.36% | 0.38% | 0.53% | 0.53% | 0.64% | |
| Earnings Yield | 2.1% | 2.0% | 5.1% | 3.2% | 4.0% | 4.5% | 2.1% | 2.8% | 3.6% | 4.1% | 3.5% | 3.1% | |
| Payout Ratio | 13.6% | 12.7% | 5.0% | 6.2% | 3.4% | 4.3% | 13.7% | 13.0% | 10.5% | 13.2% | 14.9% | 20.0% | |
| Annual Payout | $33M | $34M | $35M | $35M | $32M | $31M | $31M | $31M | $31M | $31M | $32M | $32M |
Звіт про прибутки та збитки
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $730M | $711M | $772M | $699M | $720M | $665M | $729M | $684M | $692M | $650M | $403M | $709M | $-120M | |
| Cost of Revenue | $313M | $323M | · | $324M | $328M | $289M | · | $299M | $306M | $295M | · | $307M | · | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | · | $436M | |
| R&D Expense | $49M | $58M | $58M | $51M | $53M | $54M | $49M | $49M | $48M | $50M | $45M | $57M | $40M | |
| SG&A Expense | $279M | $254M | $252M | $242M | $249M | $250M | $244M | $238M | $252M | $261M | $232M | $267M | $229M | |
| Operating Income | $89M | $76M | $112M | $82M | $91M | $72M | $119M | $98M | $86M | $44M | $-116M | $78M | $-290M | |
| Interest Expense | · | · | · | · | · | · | · | · | $25M | $24M | · | $26M | · | |
| Interest Income | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $23M | $21M | $20M | $41M | $25M | $2M | |
| Other Non-op | $21M | $-26M | $-77M | $-4M | $13M | $-20M | $-26M | $-1M | $43M | $-10M | $-27M | $-7M | $-66M | |
| Pretax Income | $64M | $50M | $92M | $56M | $69M | $52M | $95M | $100M | $87M | $35M | $-143M | $72M | $-361M | |
| Income Tax | $10M | $9M | $-4M | $8M | $13M | $11M | $6M | $7M | $14M | $6M | $-55M | $13M | $-87M | |
| Net Income | $52M | $41M | $98M | $47M | $54M | $42M | $95M | $94M | $55M | $26M | $-89M | $36M | $-166M | |
| EPS (Basic) | $0.47 | $0.36 | $0.86 | $0.40 | $0.46 | $0.35 | $0.78 | $0.77 | $0.45 | $0.21 | $-0.63 | $0.28 | $-2.50 | |
| EPS (Diluted) | $0.47 | $0.36 | $0.86 | $0.40 | $0.46 | $0.35 | $0.77 | $0.77 | $0.45 | $0.21 | $-0.63 | $0.28 | $-2.48 | |
| Shares (Basic) | 111,584,000 | 111,852,000 | · | 115,411,000 | 117,512,000 | 120,137,000 | · | 122,810,000 | 123,354,000 | 123,428,000 | · | 125,215,000 | · | |
| Shares (Diluted) | 111,629,000 | 111,876,000 | · | 115,463,000 | 117,538,000 | 120,233,000 | · | 123,026,000 | 123,477,000 | 123,538,000 | · | 125,398,000 | · | |
| EBITDA | $89M | $181M | · | $82M | $91M | $170M | · | $98M | $86M | $152M | · | $78M | · |
Баланс
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.02B | $860M | $920M | $931M | $992M | $1.14B | $1.16B | $1.23B | $1.25B | $998M | $913M | $1.33B | $454M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $706M | $697M | · | $739M | · | |
| Receivables | $709M | $691M | $745M | $680M | $661M | $617M | $632M | $602M | $597M | $589M | · | $627M | · | |
| Inventory | $379M | $388M | $379M | $380M | $388M | $381M | $368M | $405M | $401M | $414M | · | $437M | · | |
| Other Current Assets | $187M | $189M | $196M | $152M | $195M | $182M | $186M | $212M | $206M | $361M | · | $389M | · | |
| Current Assets | $2.30B | $2.13B | $2.24B | $2.14B | $2.24B | $2.32B | $2.35B | $2.45B | $3.16B | $3.06B | · | $3.52B | · | |
| PP&E (Net) | $456M | $466M | $479M | $497M | $499M | $487M | $482M | $518M | $503M | $504M | · | $491M | · | |
| PP&E (Gross) | · | · | $1.09B | · | · | · | $982M | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $614M | · | · | · | $500M | · | · | · | · | · | · | |
| Goodwill | $6.61B | $6.61B | $6.61B | $6.60B | $6.61B | $6.51B | $6.46B | $6.56B | $6.50B | $6.50B | $6.53B | $6.52B | $6.48B | |
| Intangibles | $2.22B | $2.31B | $2.35B | $2.43B | $2.51B | $2.57B | $2.64B | $2.76B | $2.83B | $2.92B | · | $3.20B | · | |
| Other Non-current Assets | $309M | $322M | $323M | $300M | $321M | $300M | $288M | $332M | $297M | $298M | · | $322M | · | |
| Total Assets | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | $12.36B | $12.39B | $12.77B | $13.42B | $13.43B | · | $14.22B | · | |
| Accounts Payable | $166M | $170M | $185M | $176M | $178M | $178M | $167M | $176M | $175M | $184M | · | $236M | · | |
| Accrued Liabilities | $538M | $493M | $557M | $463M | $493M | $470M | $485M | $510M | $504M | $479M | · | $652M | · | |
| Current Liabilities | $1.28B | $1.24B | $1.33B | $1.22B | $672M | $648M | $653M | $688M | $1.39B | $1.37B | · | $1.37B | · | |
| Capital Leases | $136M | $142M | $148M | $154M | $160M | $157M | $152M | $128M | $123M | $127M | · | $144M | · | |
| Other Non-current Liabilities | $771M | $801M | $807M | $755M | $760M | $750M | $771M | $846M | $879M | $920M | · | $954M | · | |
| Total Liabilities | $4.82B | $4.81B | $4.92B | $4.76B | $4.81B | $4.72B | $4.73B | $4.85B | $5.55B | $5.59B | · | $6.35B | · | |
| Long-term Debt | $3.21B | $3.21B | $3.22B | $3.21B | $3.21B | $3.17B | $3.15B | $3.19B | $3.87B | $3.88B | · | $4.36B | · | |
| Total Debt | $3.21B | $3.21B | · | $3.21B | $3.21B | $3.17B | · | $3.19B | $3.87B | $3.88B | · | · | · | |
| Common Stock | $112M | $112M | $112M | $114M | $116M | $119M | $121M | $122M | $123M | $123M | · | $124M | · | |
| Retained Earnings | $6.13B | $6.09B | $6.05B | $5.96B | $5.93B | $5.88B | $5.85B | $5.76B | $5.67B | $5.63B | · | $5.54B | · | |
| AOCI | $-257M | $-254M | $-222M | $-180M | $-157M | $-316M | $-396M | $-232M | $-342M | $-325M | $-277M | $-305M | $-447M | |
| Stockholders' Equity | $7.23B | $7.18B | $7.25B | $7.38B | $7.56B | $7.64B | $7.67B | $7.92B | $7.87B | $7.85B | $7.87B | $7.87B | $7.38B | |
| Liabilities + Equity | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | $12.36B | $12.39B | $12.77B | $13.42B | $13.43B | · | $14.22B | · | |
| Shares Outstanding | 111,584,000 | 111,629,000 | 112,281,000 | 114,030,000 | 116,331,000 | 119,409,000 | 120,646,000 | 122,091,000 | 123,368,000 | 123,492,000 | 0 | 124,347,000 | 0 |
Грошовий потік
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102M | $105M | $103M | $102M | $103M | $97M | $105M | $108M | $106M | $108M | $106M | · | $104M | |
| Stock-based Comp | $11M | $9M | $-4M | $9M | $10M | $8M | $5M | $11M | $12M | $12M | $7M | · | $12M | |
| Amort. of Intangibles | $85M | $85M | $84M | $84M | $85M | $83M | $88M | $90M | $91M | $91M | $85M | $93M | $163M | |
| Other Non-cash | · | $-39M | · | · | · | $-19M | · | · | · | $2M | · | · | · | |
| Operating Cash Flow | $192M | $115M | $182M | $138M | $134M | $128M | $174M | $148M | $243M | $148M | $197M | · | $139M | |
| CapEx | $11M | $20M | $20M | $19M | $19M | $16M | $24M | $22M | $19M | $18M | $24M | · | $26M | |
| Investing Cash Flow | $-4M | $-78M | $-20M | $19M | $-9M | $-6M | $-17M | $690M | $-1.76B | $-18M | $-415M | · | $-26M | |
| Stock Repurchased | $16M | $86M | $168M | $205M | $294M | $154M | $185M | $154M | $-31M | $11M | $5M | · | $25M | |
| Net Stock Activity | · | $-86M | · | · | · | $-154M | · | · | · | $-11M | · | · | · | |
| Dividends Paid | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $8M | $9M | $9M | · | $9M | |
| Financing Cash Flow | $-23M | $-89M | $-176M | $-215M | $-302M | $-164M | $-193M | $-874M | $52M | $-35M | $-20M | · | $-77M | |
| Net Change in Cash | $163M | $-60M | $-12M | $-60M | $-146M | $-26M | $-66M | $-19M | $-1.46B | $85M | $-224M | · | $54M | |
| Free Cash Flow | · | $95M | · | · | · | $112M | · | · | · | $130M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $109M | · | · | · |
Прибутковість
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.2% | 10.7% | · | 11.7% | 12.6% | 10.9% | · | 14.3% | 12.4% | 6.8% | · | 11.0% | · | |
| Net Margin | 7.1% | 5.7% | · | 6.7% | 7.5% | 6.3% | · | 13.8% | 8.0% | 4.0% | · | 5.0% | · | |
| Pretax Margin | 8.7% | 7.0% | · | 8.0% | 9.5% | 7.9% | · | 14.7% | 12.5% | 5.3% | · | 10.1% | · | |
| EBITDA Margin | 12.2% | 25.4% | · | 11.7% | 12.6% | 25.5% | · | 14.3% | 12.4% | 23.4% | · | 11.0% | · | |
| ROA | 0.42% | 0.33% | · | 0.37% | 0.42% | 0.33% | · | 0.72% | 0.40% | 0.19% | · | · | · | |
| ROE | 0.70% | 0.55% | · | 0.61% | 0.70% | 0.55% | · | 1.2% | 0.70% | 0.33% | · | · | · | |
| ROIC | 0.72% | 0.60% | · | 0.66% | 0.68% | 0.53% | · | 0.82% | 0.61% | 0.31% | · | · | · |
Ліквідність та платоспроможність
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.8 | 3.3 | 3.6 | · | 3.6 | 2.3 | 2.2 | · | · | · | |
| Quick Ratio | 1.4 | 1.3 | · | 1.3 | 2.5 | 2.7 | · | 2.7 | 1.8 | 1.7 | · | · | · | |
| Debt / Equity | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | · | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 3.5 | 1.8 | · | 3.0 | · |
Ефективність
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | · | · | |
| Receivables Turnover | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | · | · |
На акцію
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $64.78 | $64.34 | · | $64.68 | $64.95 | $63.96 | · | $64.88 | $63.80 | $63.54 | · | · | · | |
| Revenue / Share | $6.54 | $6.36 | · | $6.05 | $6.13 | $5.53 | · | $5.56 | $5.60 | $5.26 | · | $5.65 | · | |
| Cash Flow / Share | · | $1.03 | · | · | · | $1.07 | · | · | · | $1.19 | · | · | · | |
| Cash / Share | $9.17 | $7.71 | · | $8.17 | $8.53 | $9.53 | · | $10.07 | $10.12 | $8.08 | · | · | · | |
| Dividend / Share | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | $0.07 | $0.07 | $0.07 | · | $0.07 | · | |
| EPS (TTM) | $2.09 | $2.08 | · | $1.98 | $2.35 | $2.34 | · | $0.80 | $0.11 | $-0.06 | · | · | $4.50 |
Оцінка (TTM)
| Метрика | Тенденція | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.91B | $2.90B | · | $2.81B | $2.80B | $2.77B | · | $2.43B | $2.42B | $2.43B | · | · | $3.31B | |
| Net Income TTM | · | · | · | $237M | $285M | $287M | · | $87M | $2M | $-18M | · | · | $569M | |
| Market Cap | $12.69B | $9.93B | · | $9.59B | $11.38B | $12.61B | · | $15.39B | $12.94B | $12.97B | · | · | · | |
| Enterprise Value | $14.88B | $12.28B | · | $11.87B | $13.60B | $14.64B | · | $17.35B | $14.86B | $15.15B | · | · | · | |
| P/E | 54.4 | 42.8 | · | 42.5 | 41.6 | 45.1 | · | 157.6 | 953.3 | -1750.0 | · | · | 31.2 | |
| P/S | 4.4 | · | · | 3.4 | 4.1 | 4.6 | · | 6.3 | 5.4 | 5.3 | · | · | · | |
| P/B | 1.8 | 1.4 | · | 1.3 | 1.5 | 1.7 | · | 1.9 | 1.6 | 1.7 | · | · | · | |
| P / Cash Flow | · | 86.2 | · | · | · | 98.4 | · | · | · | 87.9 | · | · | · | |
| EV / Revenue | 5.1 | · | · | 4.2 | 4.9 | 5.3 | · | 7.1 | 6.1 | 6.2 | · | · | · | |
| Dividend Yield | 0.25% | · | · | 0.35% | 0.30% | 0.27% | · | 0.22% | 0.27% | · | · | · | · | |
| Earnings Yield | 1.8% | 2.3% | · | 2.4% | 2.4% | 2.2% | · | 0.63% | 0.10% | -0.06% | · | · | 3.2% | |
| Payout Ratio | · | 19.2% | · | · | · | 20.0% | · | · | · | 33.2% | · | · | · | |
| Annual Payout | $32M | $32M | · | $33M | $34M | $34M | · | $34M | $34M | · | · | · | $35M |
Найновіший період ліворуч · нульові значення показані як ·
Фінансова звітність Звіт про прибутки та збитки, баланс, рух грошових коштів — річні, за останні 5 років
| Метрика | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Виручка | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B |
| Валова маржа % | · | · | · | 60.1% | · |
| Операційна маржа % | 12.5% | 12.6% | 10.9% | 22.4% | 26.3% |
| Чистий прибуток | $241M | $270M | $693M | $569M | $943M |
| Розбавлений EPS | $2.07 | $2.20 | $5.55 | $4.50 | $8.08 |
| Метрика | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Борг / Власний капітал | 0.4 | 0.4 | 0.5 | 0.6 | 0.7 |
| Поточний коефіцієнт | 1.7 | 3.6 | 2.1 | 2.1 | 2.0 |
| Коефіцієнт швидкої ліквідності | 1.3 | 2.7 | 1.5 | 0.7 | 1.4 |
| Метрика | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 |
|---|---|---|---|---|---|
| Вільний грошовий потік | $509M | $542M | $10M | $594M | $1.31B |
Інституційні власники (13F) 577 подавачів звітності · $11.1B всього · Станом на 30 вересня 2026 р.
Інституційні інвестори, які звітують про володіння цими акціями у своїй квартальній формі SEC 13F. Тільки довгі позиції; один подавець звітності може з'явитися двічі для окремих опціонних контрактів. Великі протилежні опціонні позиції (пут/кол) зазвичай відображають маркет-мейкінг або хеджування запасів, а не спрямованість переконань.
| Нові позиції | Закриті позиції | Збільшено | Зменшено | Зміна чистих акцій |
|---|---|---|---|---|
| 101 (+19 проти попереднього кв.) | 53 (-14 проти попереднього кв.) | 195 (+16 проти попереднього кв.) | 163 (+4 проти попереднього кв.) | -8.8M |
Порівняно з Q1 2026. Звіти SEC Form 13F подаються протягом 45 днів після закінчення кварталу плюс невеликий буфер для тих, хто подає із запізненням — квартали, що ще знаходяться в цьому вікні, пропускаються на користь останньої повністю звітної пари.
| Інституційний інвестор | Вартість | Акції | % від відстежуваного 13F | Тип |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 273 316 785 | 13 160 897 | 11,42% | Акції |
| EdgePoint Investment Group Inc. | $950 658 734 | 8 544 479 | 8,53% | Акції |
| BlackRock, Inc. | $852 070 090 | 7 658 369 | 7,64% | Акції |
| VANGUARD CAPITAL MANAGEMENT LLC | $812 306 256 | 7 300 973 | 7,29% | Акції |
| JANUS HENDERSON GROUP PLC | $731 386 229 | 8 348 127 | 6,56% | Акції |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $530 760 044 | 4 770 448 | 4,76% | Акції |
| STATE STREET CORP | $483 173 141 | 4 342 739 | 4,33% | Акції |
| VICTORY CAPITAL MANAGEMENT INC | $384 362 134 | 3 454 630 | 3,45% | Акції |
| DIMENSIONAL FUND ADVISORS LP | $381 477 581 | 3 428 692 | 3,42% | Акції |
| GEODE CAPITAL MANAGEMENT, LLC | $328 197 297 | 2 955 227 | 2,94% | Акції |
| MORGAN STANLEY | $286 475 399 | 2 574 826 | 2,57% | Акції |
| Invesco Ltd. | $269 802 164 | 2 424 970 | 2,42% | Акції |
| Allspring Global Investments Holdings, LLC | $251 393 303 | 2 227 874 | 2,25% | Акції |
| NEUBERGER BERMAN GROUP LLC | $208 728 363 | 1 876 041 | 1,87% | Акції |
| UBS Group AG | $207 440 264 | 1 864 464 | 1,86% | Акції |
| Pictet Asset Management Holding SA | $181 501 112 | 1 631 343 | 1,63% | Акції |
| CITADEL ADVISORS LLC | $162 143 092 | 1 457 335 | 1,45% | Акції |
| RGM Capital, LLC | $147 000 789 | 1 519 388 | 1,32% | Акції |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $120 784 746 | 1 085 608 | 1,08% | Акції |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $120 187 725 | 1 080 242 | 1,08% | Акції |
| NORTHERN TRUST CORP | $105 092 080 | 944 563 | 0,94% | Акції |
| GOLDMAN SACHS GROUP INC | $100 173 074 | 900 351 | 0,90% | Акції |
| WELLINGTON MANAGEMENT GROUP LLP | $96 303 874 | 865 575 | 0,86% | Акції |
| NORGES BANK | $96 183 046 | 864 489 | 0,86% | Акції |
| PRIMECAP MANAGEMENT CO/CA/ | $94 921 470 | 853 150 | 0,85% | Акції |
| BANK OF AMERICA CORP /DE/ | $87 116 298 | 782 997 | 0,78% | Акції |
| Bank of New York Mellon Corp | $78 765 533 | 707 941 | 0,71% | Акції |
| VANGUARD FIDUCIARY TRUST CO | $69 620 945 | 625 750 | 0,62% | Акції |
| JANE STREET GROUP, LLC | $64 087 317 | 576 014 | 0,57% | Акції |
| JPMORGAN CHASE & CO | $54 177 057 | 481 955 | 0,49% | Акції |
| FMR LLC | $51 807 384 | 465 642 | 0,46% | Акції |
| SEI INVESTMENTS CO | $48 628 856 | 437 074 | 0,44% | Акції |
| Quantinno Capital Management LP | $47 076 898 | 423 125 | 0,42% | Акції |
| DEUTSCHE BANK AG\ | $45 437 583 | 408 391 | 0,41% | Акції |
| FEDERATED HERMES, INC. | $43 043 267 | 386 871 | 0,39% | Акції |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $42 868 033 | 385 296 | 0,38% | Акції |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $41 752 209 | 476 569 | 0,37% | Акції |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $41 048 042 | 368 938 | 0,37% | Акції |
| Freestone Grove Partners LP | $36 716 134 | 330 003 | 0,33% | Акції |
| Legal & General Group Plc | $31 388 230 | 282 116 | 0,28% | Акції |
| CIBC Bancorp USA Inc. | $29 112 955 | 261 625 | 0,26% | Акції |
| Nuveen, LLC | $27 202 014 | 244 491 | 0,24% | Акції |
| California Public Employees Retirement System | $27 021 271 | 242 866 | 0,24% | Акції |
| BNP PARIBAS FINANCIAL MARKETS | $25 920 242 | 232 970 | 0,23% | Акції |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $25 784 587 | 294 311 | 0,23% | Акції |
| Vanguard Global Advisers, LLC | $25 557 201 | 229 707 | 0,23% | Акції |
| Swiss National Bank | $24 955 618 | 224 300 | 0,22% | Акції |
| CIBC Private Wealth Group LLC | $23 946 556 | 273 207 | 0,21% | Акції |
| Artisan Partners Limited Partnership | $22 320 536 | 200 616 | 0,20% | Акції |
| Meridiem Capital Partners LP | $21 483 638 | 193 094 | 0,19% | Акції |
Активісти та власники %+ 5 2 холдинги
Інвестори, які подали Розклад SEC 13D — бенефіціарна власність понад 5% з наміром вплинути на емітента (активістські частки, кампанії в раді директорів, M&A). Кожен рядок показує останній відомий стан позиції цього подавця.
| Подавець | Подано | Частка | Статус | Мета | Подача |
|---|---|---|---|---|---|
| PERKINELMER, INC. | 16 вересня 2011 р. | · | Первинна подача | M&A / продаж | SEC |
| Нерозкрита особа, що звітує | 23 липня 2001 р. | · | Первинна подача | M&A / продаж | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Інсайдери компанії 46 інсайдерів · 27 керівники · 20 директори
| Інсайдер | Роль | Остання активність | Кількість акцій у власності | Купівлі за 12 міс. | Продажі за 12 міс. | Нетто 12 міс |
|---|---|---|---|---|---|---|
| Robert F Friel | Chairman and CEO | 13 лютого 2019 р. F | 570 662 | 0 | 0 | $0 |
| Maxwell Krakowiak | Senior Vice President and Chief Financial Officer | 21 вересня 2026 р. S | 14 781 | 0 | 1 | $-235 728 |
| James M Mock | Senior Vice President and Chief Financial Officer | 24 червня 2022 р. S | 27 577 | 0 | 0 | $0 |
| Frank Anders Wilson | Senior Vice President and Chief Financial Officer | 05 березня 2018 р. M | 61 925 | 0 | 0 | $0 |
| Jeffrey D Capello | SVP & CFO | 29 січня 2008 р. A | 91 428 | 0 | 0 | $0 |
| John Patrick Murphy | Chief Operating Officer | 01 серпня 2005 р. M | 68 589 | 0 | 0 | $0 |
| Anita Gonzales | VP and CAO | 01 жовтня 2026 р. S | 7 117 | 0 | 3 | $-29 790 |
| Tajinder Vohra | Senior Vice President, Global Operations | 16 вересня 2026 р. S | 6 635 | 0 | 2 | $-1 634 152 |
| Joel S Goldberg | Senior Vice President, Administration, General Counsel and Secretary | 14 серпня 2026 р. G | 91 494 | 0 | 4 | $-1 274 357 |
| Miriame Victor | Senior Vice President, Chief Commercial Officer | 24 лютого 2026 р. M | 18 122 | 0 | 1 | $-180 856 |
| Daniel R Tereau | Senior Vice President, Strategy and Business Development | 05 лютого 2024 р. A | 13 246 | 0 | 0 | $0 |
| Andrew Okun | Vice President, Chief Accounting Officer and Treasurer | 13 квітня 2023 р. M | 4 356 | 0 | 0 | $0 |
| Deborah A. Butters | Senior Vice President, Chief Human Resources Officer | 07 лютого 2020 р. F | 12 383 | 0 | 0 | $0 |
| James Corbett | Executive Vice President and President, Discovery & Analytical Solutions | 30 квітня 2019 р. F | 40 531 | 0 | 0 | $0 |
| Jonathan P. Divincenzo | Senior Vice President and President, Environmental Health | 09 лютого 2016 р. A | 23 158 | 0 | 0 | $0 |
| John R Letcher | Senior Vice President, Human Resources | 05 червня 2015 р. D | 26 894 | 0 | 0 | $0 |
| Maurice H. Tenney | Senior Vice President, Global Operations and Customer Logistics | 07 листопада 2014 р. D | 12 241 | 0 | 0 | $0 |
| Daniel R Marshak | SVP & CSO | 26 вересня 2014 р. D | 67 743 | 0 | 0 | $0 |
| Kevin E Hrusovsky | Senior Vice President, President Life Sciences and Technology | 31 травня 2013 р. D | 0 | 0 | 0 | $0 |
| John A Roush | Senior Vice President | 09 лютого 2010 р. A | 120 407 | 0 | 0 | $0 |
| Richard F Walsh | SVP & CAO | 26 січня 2010 р. D | 183 491 | 0 | 0 | $0 |
| Gregory L Summe | Exe. Chairman of the Board | 27 лютого 2009 р. S | 231 724 | 0 | 0 | $0 |
| Michael Louis Battles | VP & Chief Accounting Officer | 03 лютого 2009 р. A | 33 750 | 0 | 0 | $0 |
| Katherine A Ohara | SVP, Gen. Counsel, & Secretary | 29 січня 2008 р. A | 65 886 | 0 | 0 | $0 |
| Peter B Coggins | Sr. Vice President | 28 жовтня 2005 р. M | 87 070 | 0 | 0 | $0 |
| Robert A Barrett | Sr. Vice President | 03 березня 2004 р. M | 2 333 | 0 | 0 | $0 |
| Terrance L Carlson | Sr. VP & General Counsel | 27 січня 2004 р. J | 2 759 | 0 | 0 | $0 |
| Alexis P. Michas | Директор | 25 серпня 2026 р. G | 6 985 | 0 | 0 | $0 |
| Michelle Mcmurry-Heath | Директор | 07 травня 2026 р. A | 6 513 | 0 | 1 | $-58 356 |
| Michael A Klobuchar | Директор | 07 травня 2026 р. A | 7 368 | 0 | 0 | $0 |
| Pascale Witz | Директор | 07 травня 2026 р. A | 15 985 | 0 | 0 | $0 |
| Samuel R. Chapin | Директор | 07 травня 2026 р. A | 22 676 | 0 | 0 | $0 |
| Michel Vounatsos | Директор | 07 травня 2026 р. A | 13 977 | 0 | 0 | $0 |
| Frank Witney | Директор | 07 травня 2026 р. A | 23 354 | 0 | 0 | $0 |
| Sophie V. Vandebroek | Директор | 07 травня 2026 р. A | 7 368 | 0 | 0 | $0 |
| Peter Barrett | Директор | 07 травня 2026 р. A | 28 293 | 0 | 0 | $0 |
| Sylvie Gregoire | Директор | 15 травня 2023 р. A | 20 482 | 0 | 0 | $0 |
| SULLIVAN PATRICK J | Директор | 30 квітня 2019 р. A | 30 580 | 0 | 0 | $0 |
| Nicholas A Lopardo | Директор | 05 лютого 2019 р. S | 39 635 | 0 | 0 | $0 |
| Vicki L Sato | Директор | 09 лютого 2017 р. M | 29 970 | 0 | 0 | $0 |
| Kenton J Sicchitano | Директор | 24 серпня 2016 р. M | 27 971 | 0 | 0 | $0 |
| MULLEN JAMES C | Директор | 14 листопада 2014 р. M | 45 551 | 0 | 0 | $0 |
| Gabriel Schmergel | Директор | 16 лютого 2012 р. M | 48 012 | 0 | 0 | $0 |
| Robert G Tod | Директор | 14 лютого 2012 р. M | 42 824 | 0 | 0 | $0 |
| Tamara J Erickson | Директор | 14 лютого 2007 р. S | 15 352 | 0 | 0 | $0 |
| Prahlad R. Singh | · | 13 серпня 2026 р. G | 59 650 | 0 | 5 | $-2 557 859 |
Інсайдери згідно з формами SEC 3/4/5; чистий результат = лише відкритий ринок купівлі/продажу
Присутність в ETF Належить 97 ETF
Вага відображає лише прямі акціонерні володіння (N-PORT); фонди з кредитним плечем або похідними інструментами можуть мати додаткову експозицію за свопами, яка не відображається.
| Фонд | Вага | Одиниці | Станом на | Джерело |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,99% | 116 224 SH | 02 жовтня 2026 р. | Щоденно |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,13% | 6 936 NS | 31 липня 2026 р. | N-PORT |
| ALTL · Pacer Funds Trust | 0,98% | 8 002 NS | 31 липня 2026 р. | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0,83% | 53 854 SH | 02 жовтня 2026 р. | Щоденно |
| HIBL · Direxion Shares ETF Trust | 0,66% | 4 421 NS | 31 липня 2026 р. | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,62% | 61 941 SH | 02 жовтня 2026 р. | Щоденно |
| IQSM · New York Life Investments ETF Trust | 0,50% | 14 749 NS | 31 липня 2026 р. | N-PORT |
| DFSV · Dimensional ETF Trust | 0,43% | 313 113 NS | 31 липня 2026 р. | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 39 813 NS | 31 липня 2026 р. | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,36% | 14 789 NS | 31 липня 2026 р. | N-PORT |
| DFAT · Dimensional ETF Trust | 0,35% | 444 437 NS | 31 липня 2026 р. | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,33% | 36 968 SH | 02 жовтня 2026 р. | Щоденно |
| BKMC · BNY Mellon ETF Trust | 0,32% | 18 499 NS | 31 липня 2026 р. | N-PORT |
| ESML · iShares Trust | 0,29% | 66 388 SH | 11 вересня 2026 р. | Щоденно |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 49 018 NS | 31 липня 2026 р. | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,26% | 1 624 934 SH | 19 серпня 2026 р. | Щоденно |
| RSP · Invesco Exchange-Traded Fund Trust | 0,25% | 1 577 173 SH | 02 жовтня 2026 р. | Щоденно |
| IYH · iShares Trust | 0,22% | 65 502 SH | 11 вересня 2026 р. | Щоденно |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 8 343 NS | 31 липня 2026 р. | N-PORT |
| SMMD · iShares Trust | 0,19% | 59 552 SH | 11 вересня 2026 р. | Щоденно |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,18% | 5 732 000 | 02 жовтня 2026 р. | Щоденно |
| FHLC · FIDELITY COVINGTON TRUST | 0,18% | 53 129 NS | 31 липня 2026 р. | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 335 880 SH | 19 серпня 2026 р. | Щоденно |
| DFAS · Dimensional ETF Trust | 0,18% | 241 849 NS | 31 липня 2026 р. | N-PORT |
| ISCG · iShares Trust | 0,18% | 13 989 SH | 11 вересня 2026 р. | Щоденно |
| IXJ · iShares Trust | 0,17% | 58 518 SH | 11 вересня 2026 р. | Щоденно |
| REVS · Columbia ETF Trust I | 0,17% | 4 910 NS | 31 липня 2026 р. | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,15% | 2 559 509 SH | 19 серпня 2026 р. | Щоденно |
| CURE · Direxion Shares ETF Trust | 0,14% | 2 195 NS | 31 липня 2026 р. | N-PORT |
| IWS · iShares Trust | 0,13% | 167 213 SH | 11 вересня 2026 р. | Щоденно |
| WSML · iShares Trust | 0,13% | 7 071 SH | 11 вересня 2026 р. | Щоденно |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 6 250 SH | 02 жовтня 2026 р. | Щоденно |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 8 519 NS | 31 липня 2026 р. | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 4 047 000 | 02 жовтня 2026 р. | Щоденно |
| RECS · Columbia ETF Trust I | 0,11% | 55 761 NS | 31 липня 2026 р. | N-PORT |
| PEXL · Pacer Funds Trust | 0,10% | 460 NS | 31 липня 2026 р. | N-PORT |
| IWR · iShares Trust | 0,10% | 456 822 SH | 11 вересня 2026 р. | Щоденно |
| XT · iShares Trust | 0,08% | 25 072 SH | 11 вересня 2026 р. | Щоденно |
| XOEF · iShares Trust | 0,08% | 142 SH | 11 вересня 2026 р. | Щоденно |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,08% | 115 000 | 02 жовтня 2026 р. | Щоденно |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 9 258 NS | 31 липня 2026 р. | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 4 182 SH | 02 жовтня 2026 р. | Щоденно |
| DFAC · Dimensional ETF Trust | 0,06% | 238 422 NS | 31 липня 2026 р. | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 2 685 NS | 31 липня 2026 р. | N-PORT |
| DFSU · Dimensional ETF Trust | 0,05% | 10 422 NS | 31 липня 2026 р. | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,05% | 33 073 SH | 02 жовтня 2026 р. | Щоденно |
| DFUV · Dimensional ETF Trust | 0,05% | 65 386 NS | 31 липня 2026 р. | N-PORT |
| IVE · iShares Trust | 0,05% | 185 121 SH | 11 вересня 2026 р. | Щоденно |
| IUSV · iShares Trust | 0,04% | 98 188 SH | 11 вересня 2026 р. | Щоденно |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 25 806 SH | 19 серпня 2026 р. | Щоденно |
| DSI · iShares Trust | 0,04% | 17 178 SH | 11 вересня 2026 р. | Щоденно |
| DCOR · Dimensional ETF Trust | 0,04% | 11 339 NS | 31 липня 2026 р. | N-PORT |
| CHRI · Global X Funds | 0,04% | 27 NS | 31 липня 2026 р. | N-PORT |
| IWD · iShares Trust | 0,04% | 247 738 SH | 11 вересня 2026 р. | Щоденно |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 67 429 SH | 19 серпня 2026 р. | Щоденно |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 3 368 SH | 02 жовтня 2026 р. | Щоденно |
| TOPC · iShares Trust | 0,03% | 72 SH | 11 вересня 2026 р. | Щоденно |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 660 SH | 02 жовтня 2026 р. | Щоденно |
| TILT · FlexShares Trust | 0,02% | 4 536 NS | 31 липня 2026 р. | N-PORT |
| XVV · iShares Trust | 0,02% | 1 280 SH | 11 вересня 2026 р. | Щоденно |
| DFAU · Dimensional ETF Trust | 0,02% | 24 920 NS | 31 липня 2026 р. | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 89 SH | 02 жовтня 2026 р. | Щоденно |
| XYLG · Global X Funds | 0,02% | 120 NS | 31 липня 2026 р. | N-PORT |
| IVV · iShares Trust | 0,02% | 1 406 050 SH | 11 вересня 2026 р. | Щоденно |
| XYLD · Global X Funds | 0,02% | 5 804 NS | 31 липня 2026 р. | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 2 897 314 SH | 19 серпня 2026 р. | Щоденно |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 3 545 801 SH | 19 серпня 2026 р. | Щоденно |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18 403 SH | 19 серпня 2026 р. | Щоденно |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 9 418 SH | 19 серпня 2026 р. | Щоденно |
| ESGV · VANGUARD WORLD FUND | 0,02% | 25 220 SH | 19 серпня 2026 р. | Щоденно |
| IYY · iShares Trust | 0,02% | 4 913 SH | 11 вересня 2026 р. | Щоденно |
| PTLC · Pacer Funds Trust | 0,02% | 5 733 NS | 31 липня 2026 р. | N-PORT |
| IWB · iShares Trust | 0,02% | 77 050 SH | 11 вересня 2026 р. | Щоденно |
| XCLR · Global X Funds | 0,02% | 6 NS | 31 липня 2026 р. | N-PORT |
| ITOT · iShares Trust | 0,02% | 147 486 SH | 11 вересня 2026 р. | Щоденно |
| IWV · iShares Trust | 0,02% | 30 674 SH | 11 вересня 2026 р. | Щоденно |
| DFUS · Dimensional ETF Trust | 0,02% | 33 978 NS | 31 липня 2026 р. | N-PORT |
| XRMI · Global X Funds | 0,02% | 81 NS | 31 липня 2026 р. | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,02% | 421 NS | 31 липня 2026 р. | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 11 711 SH | 02 жовтня 2026 р. | Щоденно |
| QDPL · Pacer Funds Trust | 0,02% | 2 684 NS | 31 липня 2026 р. | N-PORT |
| XTR · Global X Funds | 0,02% | 7 NS | 31 липня 2026 р. | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,02% | 779 NS | 31 липня 2026 р. | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,01% | 8 723 NS | 31 липня 2026 р. | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 3 421 SH | 02 жовтня 2026 р. | Щоденно |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 98 929 SH | 19 серпня 2026 р. | Щоденно |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 липня 2026 р. | Щоденно |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 липня 2026 р. | Щоденно |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 липня 2026 р. | Щоденно |
| ISCB · iShares Trust | · | 5 032 SH | 11 вересня 2026 р. | Щоденно |
| ISCV · iShares Trust | · | 15 028 SH | 11 вересня 2026 р. | Щоденно |
RVTY Консенсус аналітиків Бичачі та ведмежі думки аналітиків, 12-місячна цільова ціна, потенціал зростання
12-місячна цільова ціна
16 аналітиків · 2026-09-28Середня цільова ціна $129.00 -14,9%
Порівняння з аналогами (підгалузь GICS) Ключові показники порівняно з аналогами в секторі
База за фінансовий рік, ціни на момент закриття останнього фінансового року кожної компанії.
| Тікер | Капіталізація | P/E | Виручка рік до року | Чиста маржа | ROE | Валова маржа |
|---|---|---|---|---|---|---|
| RVTY | $10.86B | 46.7 | 3.7% | 8.5% | 3.3% | · |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | · |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | · |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
Мої показники Ваш персональний список спостереження — вибрані рядки з Повних фундаментальних даних
Виберіть показники, які для вас важливі — натисніть + поруч із будь-яким рядком у розділі Повна фундаментальна інформація вище.
Ваш вибір збережено і він буде застосовуватися до всіх тікерів.